Xenon Pharmaceuticals Inc. (XENE) has a market capitalization of $4.69B and trades at $59.35. The 52-week range is 26.74-63.95.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.6, Earnings Per Share (EPS) of $-4.36, annual revenue of $7.5M.
The stock has a beta of 0.75, operates in the Healthcare sector.
